Learn more →
Back to Expert Scholars
Immunotherapy / 免疫治疗Cancer Immunology

Shimon Sakaguchi

坂口志文

MD, PhD

🏢Osaka University Immunology Frontier Research Center(大阪大学免疫学前沿研究中心)🌐Japan

Distinguished Professor and Director, Department of Experimental Immunology实验免疫学系杰出教授兼主任

145
h-index
2
Key Papers
7
Awards
3
Key Contributions

👥Biography 个人简介

Shimon Sakaguchi at Osaka University is the discoverer of CD4+CD25+ regulatory T cells (Tregs) and FOXP3 as their master transcription factor. His seminal discoveries established the modern framework of Treg biology, immune tolerance, and tumor immune suppression, making him one of the most cited and influential immunologists worldwide.

Share:

🧪Research Fields 研究领域

Regulatory T Cells调节性T细胞
FOXP3 Transcription FactorFOXP3转录因子
Immune Tolerance免疫耐受
Autoimmunity and Cancer自身免疫与癌症
Tumor Immune Suppression肿瘤免疫抑制

🎓Key Contributions 主要贡献

Discovery of CD4+CD25+ Regulatory T Cells

Discovered that a distinct population of CD4+CD25+ T cells actively suppresses autoreactive immune responses, establishing regulatory T cells as a fundamental mechanism of peripheral tolerance and a major axis of tumor immune escape.

FOXP3 as Master Transcription Factor of Tregs

Identified FOXP3 as the lineage-defining transcription factor of regulatory T cells, showing that FOXP3 expression is sufficient to confer suppressive function and that mutations cause the scurfy/IPEX autoimmune syndrome.

Treg-Mediated Tumor Immune Escape and Therapeutic Targeting

Demonstrated that Tregs are enriched in human tumor microenvironments and that depletion of Tregs enhances anti-tumor immunity, establishing Treg targeting as a therapeutic strategy in cancer immunotherapy.

Representative Works 代表性著作

[1]

Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25)

Journal of Immunology (1995)

Landmark discovery paper establishing that CD4+CD25+ T cells suppress autoreactive responses, founding the modern regulatory T cell field with over 12,000 citations.

[2]

FOXP3+ regulatory T cells in the tumor microenvironment: their role in tumor immunity and as a therapeutic target

Nature Reviews Immunology (2020)

Comprehensive review of Treg biology in cancer, covering FOXP3 mechanisms, tumor enrichment, immune suppression, and therapeutic targeting approaches.

🏆Awards & Recognition 奖项与荣誉

🏆Crafoord Prize
🏆Heineken Prize for Medicine
🏆William B. Coley Award
🏆Robert Koch Prize
🏆Member, Japan Academy
🏆ISAC William Paul Award
🏆Highly Cited Researcher (Clarivate Analytics)

📄Data Sources 数据来源

Last updated: 2026-01-15 | All information from publicly available academic sources

关注 坂口志文 的研究动态

Follow Shimon Sakaguchi's research updates

留下邮箱,当我们发布与 Shimon Sakaguchi(Osaka University Immunology Frontier Research Center)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment